Infectious Diseases and Clinical Microbiology

Dr. Rehile Zengin

Doctor and researcher Acıbadem Altunizade Hastanesi İstanbul
COVID-19BacteremiaPneumonia, ViralCoronavirus Infections
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • COVID-19 4 publications
    Source: OpenAlex / PubMed MeSHView publications
  • Bacteremia 2 publications
  • Pneumonia, Viral 2 publications
  • Coronavirus Infections 2 publications

Person ↔ Disease

Which topics does this doctor work on?

From source

Medical areas of interest the doctor lists on their own profile on the institution’s website. Source: acibadem.com.tr.

  • Cinsel Yolla Bulaşan Hastalıklar
  • Frengi (Sifiliz)
  • Alt Solunum Yolları Enfeksiyonu (Bronşit, Zatürre -Pnömoni)
  • Bulaşıcı Hastalıklar
  • Hepatit Hastalıkları
  • HIV ve AIDS
  • HPV
  • Cilt, Doku ve Yara Enfeksiyonları (Zona, Döküntüler, Diyabetik Ayak ve Cerrahi Yara Enfeksiyonları)
  • Erişkin Aşılamaları
  • Seyahat Sağlığı
  • Alt Solunum Yolları Enfeksiyonu
  • Cilt Enfeksiyonları

CV

Education and experience

From source

Experience

  • 2017Altunizade Acıbadem Hastanesi / Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Kliniği / Uzman Doktor / Halenacibadem.com.tr
  • 2013 - 2017Maslak Acıbadem Hastanesi Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Kliniği / Uzman Doktoracibadem.com.tr
  • 2013Sağlık Bilimleri Üniversitesi Haydarpaşa Nümune Eğitim ve Araştırma Hastanesi Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Kliniği / Araştırma Görevlisiacibadem.com.tr
  • 2013Sağlık Bilimleri Üniversitesi Haydarpaşa Nümune Eğitim ve Araştırma Hastanesi Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Kliniği / Gözlemci Doktoracibadem.com.tr
  • 2010Acıbadem Sağlık Grubuacibadem.com.tr
  • 2007 - 2011Azerbaycan Tıp Üniversitesi Tıp Fakültesi Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji ABD / Araştırma Görevlisiacibadem.com.tr

Education

  • 2013Azerbaycan Tıp Üniversitesi, Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji, Uzmanlıkacibadem.com.tr
  • 2007Azerbaycan Tıp Üniversitesi Tıp Fakültesi, Üniversiteacibadem.com.tr

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyInfectious Diseases and Clinical Microbiologyacibadem.com.trFrom source
  • InstitutionAcıbadem Altunizade Hastanesiacibadem.com.trFrom source
  • Area of workCOVID-19Extracted from 4 publications · Model version —From source
  • Publications27 publicationsOpenAlexFrom source
  • Last synchronised4 November 2026 21:03https://www.acibadem.com.tr/doktor/rehile-zengin/acibadem.com.tr

Scientific work

Publications on COVID-19

27 publications
Publications by year Most: 9, in 2020
  1. 2020: 9 publications
  2. 2021: 3 publications
  3. 2022: 1 publication
  4. 2023: 4 publications
  5. 2024: 5 publications
  6. 2025: 2 publications

  1. P-2333. Evaluation of Clinical Characteristics, Risk Factors and Prognosis of Herpes Zoster (Shingles) Infection in Türkiye: VARICOMP-Adult-2 Study

    Open Forum Infectious Diseases, 2025

    DOI 10.1093/ofid/ofae631.2485 Open-access full textSource: OpenAlex

  2. Evaluation of clinical characteristics, risk factors and prognosis of herpes zoster (shingles) infection in Türkiye: VARICOMP-adult-2 study

    International Journal of Infectious Diseases, 2025

    DOI 10.1016/j.ijid.2025.108105 PMID 41067603 Open-access full textSource: OpenAlex

  3. Multicenter evaluation of ceftazidime-avibactam use in carbapenem-resistant Klebsiella pneumoniae bloodstream infections in OXA-48 endemic regions

    Scientific Reports, 2024

    DOI 10.1038/s41598-024-77259-z PMID 39487308 11 citations (Europe PMC) Open-access full textSource: OpenAlex

  4. The usage of immunosuppressant agents and secondary infections in patients with COVID-19 in the intensive care unit: a retrospective study

    Scientific Reports, 2024

    DOI 10.1038/s41598-024-71912-3 PMID 39251824 2 citations (Europe PMC) Open-access full textSource: OpenAlex

  5. Ceftazidime–Avibactam Versus Polymyxin-Based Combination Therapies: A Study on 30-Day Mortality in Carbapenem-Resistant Enterobacterales Bloodstream Infections in an OXA-48-Endemic Region

    Antibiotics, 2024

    DOI 10.3390/antibiotics13100990 PMID 39452256 7 citations (Europe PMC) Open-access full textSource: OpenAlex

  6. Can CMV reactivation be a biomarker of persistent inflammation, immunosuppression, and catabolism syndrome?

    Journal of Critical Care, 2024

    DOI 10.1016/j.jcrc.2024.154742 Source: OpenAlex

  7. Ceftazidime-Avibactam versus Polymyxin-Based Therapies: A Study on 30-Day Mortality in Carbapenem-Resistant Enterobacterales Bloodstream Infections in an OXA-48 Endemic Region

    Journal of Global Antimicrobial Resistance, 2024

    DOI 10.1016/j.jgar.2024.10.005 Open-access full textSource: OpenAlex

  8. Effectiveness of ACB-IP 1.0 Universal Pathogen Free Concentrated Cocktail Convalescent Plasma in COVID-19 Infection

    Research Square, 2023

    DOI 10.21203/rs.3.rs-1042702/v2 Source: OpenAlex

  9. Effectiveness of ACB-IP 1.0 Universal Pathogen Free Concentrated Cocktail Convalescent Plasma in COVID-19 Infection

    Research Square, 2023

    DOI 10.21203/rs.3.rs-1042702/v3 Open-access full textSource: OpenAlex

  10. P1397: THIRD-PARTY MULTIVIRUS-SPECIFIC T CELLS FOR THE TREATMENT OF REFRACTORY VIRAL INFECTIONS AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION

    HemaSphere, 2023

    DOI 10.1097/01.hs9.0000972476.61639.77 Source: OpenAlex

View all 27 publications